Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-21-000473
Filing Date
2021-11-09
Accepted
2021-11-09 12:23:44
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING REGENXBIO INC. REGENXBIO_Inc.htm SC 13G/A 88046
  Complete submission text file 0000019617-21-000473.txt   90011
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89108
SIC: 2836 Biological Products, (No Diagnostic Substances)